Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

Is Tailoring of Chemotherapy in HER2-Positive Breast Cancer Feasible?

In a randomized trial, women with amplification of the HER2 gene responded better to an anthracycline-based chemotherapy regimen.

Sign In

Don't yet have a username or password?

Journal Watch e-mail alerts and unlimited online access to articles 6 months after publication.

Full, immediate online access to all Journal Watch content and services.

Already a subscriber? Activate your subscription to receive full online access.

Get full site access with a 7-day site pass for $19